[Use of ketogenic diet in treatment of pharmacoresistant epilepsy].
Ketogenic diet (KD) is one of the most effective methods of epilepsy non-drug therapy. Ten patients with pharmacoresistant epilepsy, aged 1.5-18 years, were treated with individually matched and strictly controlled KD with high fat content and restricted amount of proteins and carbohydrates. After 1 year, only 4 patients kept the diet. Factors of efficacy, causes of withdrawal and side effects of KD are discussed.
Usacheva
E L
EL
Aĭvazian
S O
SO
Sorvacheva
T N
TN
Pyr'eva
E A
EA
Kon'
I Ia
IIa
Zenkov
L R
LR
Shorina
M Iu
MIu
Osipova
K V
KV
Prityko
A G
AG
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D004040:Dietary Carbohydrates / Q000008:administration & dosage; D004041:Dietary Fats / Q000008:administration & dosage / Q000627:therapeutic use*; D004044:Dietary Proteins / Q000008:administration & dosage; D004351:Drug Resistance; D004827:Epilepsy / Q000178:diet therapy* / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D007223:Infant; D007657:Ketone Bodies / Q000096:biosynthesis*; D008297:Male; D016896:Treatment Outcome
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D007657:Ketone Bodies